Clinical osteoarthritis predicts physical and psychological QoL in acromegaly patients

Growth Hormone and IGF Research

Volumn 20, Issue 3, 2010, Pages 226-233

  Wassenaar, M J E ^a   Biermasz, N R ^a   Kloppenburg, M ^a   Klaauw, A A van der ^a   Tiemensma, J ^a   Smit, J W A ^a   Pereira, A M ^a   Roelfsema, F ^a   Kroon, H M ^a   Romijn, J A ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Acromegaly; Arthropathy; Growth hormone; Insulin like growth factor type I; Osteoarthritis; Quality of life

Indexed keywords

ACROMEGALY; ADULT; AGED; ANXIETY; ARTHROPATHY; ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE CONTROL; FEMALE; FUNCTIONAL DISEASE; HIP PAIN; HUMAN; KNEE PAIN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MUSCLE STIFFNESS; OSTEOARTHRITIS; PRIORITY JOURNAL; PSYCHOLOGICAL WELL BEING; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SELF REPORT; SHORT FORM 36; SOCIAL INTERACTION; SPINAL PAIN; SPONDYLOSIS;

ACROMEGALY; ADAPTATION, PSYCHOLOGICAL; ARTHROGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; JOINT DISEASES; MALE; MIDDLE AGED; MOTOR ACTIVITY; OSTEOARTHRITIS; PAIN; PREVALENCE; PROGNOSIS; QUALITY OF LIFE; RESEARCH DESIGN;

EID: 77953081294     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2010.02.003     Document Type: Article

References (34)

1. Biermasz N.R., Pereira A.M., Smit J.W., Romijn J.A., Roelfsema F. Morbidity after long-term remission for acromegaly: persisting joint-related complaints cause reduced quality of life. J. Clin. Endocrinol. Metab. 2005, 90:2731-2739.
2. Bluestone R., Bywaters E.G., Hartog M., Holt P.J., Hyde S. Acromegalic arthropathy. Ann. Rheum. Dis. 1971, 30:243-258.
3. Hua S.C., Yan Y.H., Chang T.C. Associations of remission status and lanreotide treatment with quality of life in patients with treated acromegaly. Eur. J. Endocrinol. 2006, 155:831-837.
4. Kauppinen-Makelin R., Sane T., Sintonen H., et al. Quality of life in treated patients with acromegaly. J. Clin. Endocrinol. Metab. 2006, 91:3891-3896.
5. Trepp R., Everts R., Stettler C., et al. Assessment of quality of life in patients with uncontrolled vs. controlled acromegaly using the Acromegaly Quality of Life Questionnaire (AcroQoL). Clin. Endocrinol. (Oxf). 2005, 63:103-110.
6. Webb S.M., Badia X., Surinach N.L. Validity and clinical applicability of the acromegaly quality of life questionnaire, AcroQoL: a 6-month prospective study. Eur. J. Endocrinol. 2006, 155:269-277.
7. Rowles S.V., Prieto L., Badia X., Shalet S.M., Webb S.M., Trainer P.J. Quality of life (QOL) in patients with acromegaly is severely impaired: use of a novel measure of QOL: acromegaly quality of life questionnaire. J. Clin. Endocrinol. Metab. 2005, 90:3337-3341.
8. Biermasz N.R., van Thiel S.W., Pereira A.M., et al. Decreased quality of life in patients with acromegaly despite long-term cure of growth hormone excess. J. Clin. Endocrinol. Metab. 2004, 89:5369-5376.
9. van der Klaauw A.A., Biermasz N.R., Hoftijzer H.C., Pereira A.M., Romijn J.A. Previous radiotherapy negatively influences quality of life during 4 years of follow-up in patients cured from acromegaly. Clin. Endocrinol. (Oxf). 2008, 69:123-128.
10. Neggers S.J., van Aken M.O., de Herder W.W., et al. Quality of life in acromegalic patients during long-term somatostatin analog treatment with and without pegvisomant. J. Clin. Endocrinol. Metab. 2008, 93:3853-3859.
11. Paisley A.N., Rowles S.V., Roberts M.E., et al. Treatment of acromegaly improves quality of life, measured by AcroQol. Clin. Endocrinol. (Oxf). 2007, 67:358-362.
12. Wassenaar M.J., Biermasz N.R., van Duinen N., et al. High prevalence of arthropathy, according to the definitions of radiological and clinical osteoarthritis, in patients with long-term cure of acromegaly: a case-control study. Eur. J. Endocrinol. 2009, 160:357-365.
13. van der Waal J.M., Terwee C.B., van der Windt D.A., Bouter L.M., Dekker J. The impact of non-traumatic hip and knee disorders on health-related quality of life as measured with the SF-36 or SF-12; a systematic review. Qual. Life. Res. 2005, 14:1141-1155.
14. Zigmond A.S., Snaith R.P. The hospital anxiety and depression scale. Acta Psychiatr. Scand. 1983, 67:361-370.
15. Smets E.M., Garssen B., Bonke B., de Haes J.C. The multidimensional fatigue inventory (MFI) psychometric qualities of an instrument to assess fatigue. J. Psychosom. Res. 1995, 39:315-325.
16. Hunt S.M., McKenna S.P., McEwen J., Backett E.M., Williams J., Papp E. A quantitative approach to perceived health status: a validation study. J. Epidemiol. Community Health 1980, 34:281-286.
17. Hunt S.M., McEwen J. The development of a subjective health indicator. Sociol. Health Illn. 1980, 2:231-246.
18. Brazier J.E., Harper R., Jones N.M., et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ 1992, 305:160-164.
19. Ware J.E., Sherbourne C.D. The MOS 36-item short-form health survey (SF-36); I. Conceptual framework and item selection. Med. Care. 1992, 30:473-483.
20. Webb S.M., Prieto L., Badia X., et al. Acromegaly Quality of Life Questionnaire (AcroQoL) a new health-related quality of life questionnaire for patients with acromegaly: development and psychometric properties. Clin. Endocrinol. (Oxf). 2002, 57:251-258.
21. Janssen Y.J., Frolich M., Roelfsema F. A low starting dose of genotropin in growth hormone-deficient adults. J. Clin. Endocrinol. Metab. 1997, 82:129-135.
22. Cole T.J. The LMS method for constructing normalized growth standards. Eur. J. Clin. Nutr. 1990, 44:45-60.
23. Rikken B., Ringeling A., van den Brande J.L., Massa G., Wit J.M. Plasma levels of insulin-like growth factor (IGF)-I, IGF-II and IGF-binding protein-3 in the evaluation of childhood growth hormone deficiency. Horm. Res. 1998, 50:166-176.
24. Peterfy C., Li J., Zaim S., et al. Comparison of fixed-flexion positioning with fluoroscopic semi-flexed positioning for quantifying radiographic joint-space width in the knee: test-retest reproducibility. Skeletal Radiol. 2003, 32:128-132.
25. Kellgren J.H., Lawrence J.S. Radiological assessment of osteo-arthrosis. Ann. Rheum. Dis. 1957, 16:494-502.
26. Altman R., Alarcon G., Appelrouth D., et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum. 1991, 34:505-514.
27. Altman R., Asch E., Bloch D., et al. Development of criteria for the classification and reporting of osteoarthritis; classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum. 1986, 29:1039-1049.
28. Carragee E.J. Psychological and functional profiles in select subjects with low back pain. Spine J. 2001, 1:198-204.
29. Ehrlich G.E. The rise of osteoarthritis. Bull. World Health Organ. 2003, 81:630.
30. Slatkowsky-Christensen B., Mowinckel P., Loge J.H., Kvien T.K. Health-related quality of life in women with symptomatic hand osteoarthritis: a comparison with rheumatoid arthritis patients: healthy controls, and normative data. Arthritis Rheum. 2007, 57:1404-1409.
31. van Saase J.L., van Romunde L.K., Cats A., Vandenbroucke J.P., Valkenburg H.A. Epidemiology of osteoarthritis: Zoetermeer survey. Comparison of radiological osteoarthritis in a Dutch population with that in 10 other populations. Ann. Rheum. Dis. 1989, 48:271-280.
32. Colao A., Marzullo P., Vallone G., et al. Reversibility of joint thickening in acromegalic patients: an ultrasonography study. J. Clin. Endocrinol. Metab. 1998, 83:2121-2125.
33. J.H. Klippel, P. Dieppe, F.F. Ferri, Primary care rheumatology, C.V. Mosby, 1999.
34. Millar A., Doll H., David J., Wass J. Impact of musculoskeletal disease on quality of life in long-standing acromegaly. Eur. J. Endocr. 2008, 158:587-593.